JP2022509065A5 - - Google Patents
Info
- Publication number
- JP2022509065A5 JP2022509065A5 JP2021526658A JP2021526658A JP2022509065A5 JP 2022509065 A5 JP2022509065 A5 JP 2022509065A5 JP 2021526658 A JP2021526658 A JP 2021526658A JP 2021526658 A JP2021526658 A JP 2021526658A JP 2022509065 A5 JP2022509065 A5 JP 2022509065A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cancer
- sirpα
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18206594.6 | 2018-11-15 | ||
| EP18206594 | 2018-11-15 | ||
| PCT/EP2019/081523 WO2020099653A1 (en) | 2018-11-15 | 2019-11-15 | HUMANIZED ANTI-SIRPα ANTIBODIES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509065A JP2022509065A (ja) | 2022-01-20 |
| JP2022509065A5 true JP2022509065A5 (cg-RX-API-DMAC7.html) | 2022-11-02 |
| JP7451520B2 JP7451520B2 (ja) | 2024-03-18 |
Family
ID=64331834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526658A Active JP7451520B2 (ja) | 2018-11-15 | 2019-11-15 | ヒト化抗SIRPα抗体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12180295B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3880707A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7451520B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102955590B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113412279B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019378101B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021009275A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3118966A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2021001260A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL282756A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021005761A (cg-RX-API-DMAC7.html) |
| MY (1) | MY204673A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202104431PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020099653A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12018550160B1 (en) | 2016-04-14 | 2024-07-03 | Ose Immunotherapeutics | NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS |
| JOP20190009A1 (ar) | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها |
| CN110325549B (zh) | 2016-12-09 | 2024-03-08 | 艾利妥 | 抗SIRPα抗体及其使用方法 |
| JP7160833B2 (ja) * | 2017-04-13 | 2022-10-25 | サイロパ ビー.ブイ. | 抗sirpアルファ抗体 |
| WO2019183266A1 (en) | 2018-03-21 | 2019-09-26 | ALX Oncology Inc. | Antibodies against signal-regulatory protein alpha and methods of use |
| CR20200566A (es) | 2018-05-25 | 2021-02-19 | Alector Llc | Anticuerpos anti-sirpa y metodos de utilización de los mismos |
| US20230414778A1 (en) * | 2020-11-11 | 2023-12-28 | Daiichi Sankyo Company, Limited | COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH ANTI-SIRPalpha ANTIBODY |
| CN112574310B (zh) * | 2020-12-11 | 2023-05-05 | 浙江博锐生物制药有限公司 | 抗SIRPα抗体及其用途 |
| CN114790241B (zh) * | 2021-01-26 | 2024-12-13 | 北京免疫方舟医药科技有限公司 | 抗tigit抗体及其应用 |
| AU2022284373A1 (en) * | 2021-06-04 | 2024-01-04 | Boehringer Ingelheim International Gmbh | Anti-sirp-alpha antibodies |
| TW202408584A (zh) * | 2022-05-10 | 2024-03-01 | 日商第一三共股份有限公司 | 抗體-藥物結合物與抗SIRPα抗體之組合 |
| WO2024105180A1 (en) | 2022-11-16 | 2024-05-23 | Boehringer Ingelheim International Gmbh | Predictive efficacy biomarkers for anti-sirpa antibodies |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| EP1244707A1 (de) | 1999-11-30 | 2002-10-02 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Antikörper gegen signal-regulator-proteine |
| EP3342782B1 (en) | 2004-07-15 | 2022-08-17 | Xencor, Inc. | Optimized fc variants |
| PT2474557E (pt) | 2007-07-16 | 2014-12-03 | Genentech Inc | Anticorpos e imunoconjugados anti-cd79b e métodos de utilização |
| EP2111869A1 (en) | 2008-04-23 | 2009-10-28 | Stichting Sanquin Bloedvoorziening | Compositions and methods to enhance the immune system |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| CN101880324B (zh) * | 2010-05-25 | 2012-10-17 | 中国人民解放军第二军医大学 | 一种抗人SIRPα的单克隆抗体及其细胞株、制备方法和应用 |
| JP5940093B2 (ja) | 2011-01-19 | 2016-06-29 | カンタージア アクチエボラーグ | 抗il−1rap抗体及びヒトを処置するためのそれらの使用 |
| MX2013014789A (es) * | 2011-06-16 | 2014-01-20 | Novartis Ag | Proteinas solubles para utilizarse como productos terapeuticos. |
| WO2013056352A1 (en) | 2011-10-19 | 2013-04-25 | University Health Network | Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers |
| KR101674784B1 (ko) | 2012-04-05 | 2016-11-09 | 에프. 호프만-라 로슈 아게 | 인간 tweak 및 인간 il17에 대한 이중특이적 항체 및 이의 용도 |
| WO2013180200A1 (ja) | 2012-05-30 | 2013-12-05 | 中外製薬株式会社 | 標的組織特異的抗原結合分子 |
| RU2681994C2 (ru) * | 2012-12-26 | 2019-03-14 | Онкосинерджи, Инк. | КОМПОЗИЦИИ АНТИТЕЛА К ИНТЕГРИНУ β1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| CN103665165B (zh) * | 2013-08-28 | 2016-02-24 | 江苏匡亚生物医药科技有限公司 | 一种靶向人CD47-SIRPα信号通路的双特异性抗体及其制备方法和用途 |
| WO2015138600A2 (en) | 2014-03-11 | 2015-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies |
| ES2751915T5 (es) * | 2014-08-15 | 2022-12-23 | Merck Patent Gmbh | Proteínas de fusión de inmunoglobulina con SIRP alfa |
| DK3298043T3 (da) | 2015-05-18 | 2021-02-15 | Ab Initio Biotherapeutics Inc | SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse |
| DK4186927T3 (da) | 2015-10-21 | 2025-06-10 | Ose Immunotherapeutics | Fremgangsmåder og sammensætninger til at ændre makrofagers polarisering til pro-inflammatoriske celler til behandling af kræft |
| EP3493845A4 (en) | 2016-08-03 | 2020-04-15 | The Board of Trustees of the Leland Stanford Junior University | INTERRUPTION OF FC RECEPTOR USE ON MACROPHAGES TO IMPROVE THE EFFECTIVENESS OF ANTI-SIRPALPHA ANTIBODY THERAPY |
| JOP20190009A1 (ar) * | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها |
| CN110325549B (zh) * | 2016-12-09 | 2024-03-08 | 艾利妥 | 抗SIRPα抗体及其使用方法 |
| PT3443010T (pt) * | 2017-02-17 | 2024-10-21 | Ose Immunotherapeutics | Novos anticorpos anti-sirpa e suas aplicações terapêuticas |
| JP7160833B2 (ja) | 2017-04-13 | 2022-10-25 | サイロパ ビー.ブイ. | 抗sirpアルファ抗体 |
| PT3625259T (pt) * | 2017-05-16 | 2024-07-04 | Synthon Biopharmaceuticals Bv | Anticorpos anti-sirpalfa |
| EP3658589B1 (en) | 2017-07-26 | 2023-09-27 | Forty Seven, Inc. | Anti-sirp-alpha antibodies and related methods |
-
2019
- 2019-11-15 CN CN201980088956.2A patent/CN113412279B/zh active Active
- 2019-11-15 US US17/292,182 patent/US12180295B2/en active Active
- 2019-11-15 KR KR1020217016769A patent/KR102955590B1/ko active Active
- 2019-11-15 JP JP2021526658A patent/JP7451520B2/ja active Active
- 2019-11-15 MY MYPI2021002647A patent/MY204673A/en unknown
- 2019-11-15 BR BR112021009275A patent/BR112021009275A2/pt unknown
- 2019-11-15 MX MX2021005761A patent/MX2021005761A/es unknown
- 2019-11-15 CA CA3118966A patent/CA3118966A1/en active Pending
- 2019-11-15 AU AU2019378101A patent/AU2019378101B2/en active Active
- 2019-11-15 EP EP19808550.8A patent/EP3880707A1/en active Pending
- 2019-11-15 SG SG11202104431PA patent/SG11202104431PA/en unknown
- 2019-11-15 WO PCT/EP2019/081523 patent/WO2020099653A1/en not_active Ceased
-
2021
- 2021-04-28 IL IL282756A patent/IL282756A/en unknown
- 2021-05-13 CL CL2021001260A patent/CL2021001260A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524249A5 (cg-RX-API-DMAC7.html) | ||
| US11591400B2 (en) | B7-H3 directed antibody drug conjugates | |
| JP2020520370A5 (cg-RX-API-DMAC7.html) | ||
| JP7840511B2 (ja) | 抗クローディン18抗体及びそれらの使用の方法 | |
| US11136413B2 (en) | PDL-1 antibody, pharmaceutical composition thereof, and uses thereof | |
| CA2991880C (en) | ANTIBODIES BINDING TO HUMAN CD3 | |
| IL258202B2 (en) | CD3-binding polypeptides, a method for their preparation, pharmaceutical preparations, nucleic acids, vectors and the use of such polypeptides | |
| KR102790232B1 (ko) | Cd70 병용 요법 | |
| JP2022505871A5 (cg-RX-API-DMAC7.html) | ||
| AU2018268304A1 (en) | Anti-SIRPα antibodies | |
| CA3193662A1 (en) | Pharmaceutical combination containing anti-pd-1-anti-vegfa bispecific antibody, and use thereof | |
| JP2024515396A5 (cg-RX-API-DMAC7.html) | ||
| US20240327543A1 (en) | Multispecific antigen-binding protein and use thereof | |
| CN103768596B (zh) | 用于肿瘤治疗的组合产品、其用途及相关方法 | |
| RU2021116831A (ru) | ГУМАНИЗИРОВАННЫЕ АНТИ-SIRPα АНТИТЕЛА | |
| WO2025157223A1 (en) | Multispecific antibodies and uses thereof | |
| US20250138018A1 (en) | T cell and nk cell engagers | |
| WO2025175056A1 (en) | Multispecific antibodies or antigen binding fragments thereof to b7-h7 and immune effector cell antigens | |
| HK40123160A (en) | Pharmaceutical use of anti-pd-1-anti-vegfa bispecific antibody | |
| HK40114665A (en) | Pharmaceutical combination comprising an anti-ctla4-anti-pd-1 bispecific antibody and use thereof | |
| CA3232304A1 (en) | Use of anti-cd40 antibody | |
| HK40091003A (en) | Pharmaceutical combination containing anti-pd-1-anti-vegfa bispecific antibody, and use thereof | |
| HK40064186A (en) | Anti-claudin 18 antibodies and methods of use thereof | |
| CN118615438A (zh) | 包含抗ctla4-抗pd-1双特异性抗体的药物组合及其用途 | |
| TH2101000290A (th) | องค์ประกอบของแอนติ-cd112r และวิธีการ |